Search for: "WASHINGTON v. GENERAL MOTORS, INC." Results 101 - 120 of 169
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
28 Mar 2008, 6:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Forbes interview with M Meurer (co author of ‘Patent Failure’): (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (IAM), (Technological Innovation and Intellectual Property), (Patent Prospector),Rambus – Rambus stock soars following jury’s dismissal of antitrust and fraud charges from Hynix, Micron, and Nanya that… [read post]
14 Jan 2020, 9:07 am by John Elwood
(relisted after the January 10 conference) Arlene’s Flowers, Inc. v. [read post]
29 Feb 2008, 8:00 am
, (EDTexweblog.com), (Patent Prospector), (Peter Zura's 271 Patent Blog), (IPBiz), (Against Monopoly), (Philip Brooks), (IPBiz), Indian government to consider whether to grant compulsory licenses to Natco for the exportation of generic versions of Tarceva and Sutent (Sunitinib) to Nepal : (Spicy IP), (Spicy IP), (Spicy IP), (Generic Pharmaceuticals & IP), (IP Law360), (Spicy IP),GlobalGlobal - GeneralIntellectual privilege or imaginary property? [read post]
15 Mar 2013, 6:03 am by Lyle Denniston
  Arguing for state and local officials in Arizona v. [read post]
11 May 2020, 1:09 am by Schachtman
In the face of this traditional judicial lassitude, “[v]igorous cross-examination, presentation of contrary evidence, and careful instruction on the burden of proof” were all a litigant could hope to accomplish in litigation. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
26 Jun 2015, 1:08 pm by John Elwood
The denial in Ford Motor Company v. [read post]
25 Apr 2015, 11:03 am by Schachtman
Green, “Reference Guide on Epidemiology,” in Federal Judicial Center, Reference Manual on Scientific Evidence 123, 150, 168 (Washington, DC:, 1st ed., 1994) (“The relative risk from an epidemiological study can be adapted to this 50% plus standard to yield a probability or likelihood that an agent caused an individual’s disease. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
14 Jul 2009, 6:37 am
(Editor’s Note: This post comes to us from Katrina Dewey, CEO & Publisher, Lawdragon, Inc.) [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
25 Jun 2023, 10:54 am by Eugene Volokh
Like other advocacy, advocacy of boycotts is generally constitutionally protected: NAACP v. [read post]